Dallah Healthcare Company (4004.SR) — Financial statements
Income statement, balance sheet, and cash flow for Dallah Healthcare Company — annual and quarterly history with growth and margin analysis.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 4,067↑26.9% | 3,206↑8.9% | 2,943↑18.3% | 2,488↑18.2% | 2,105 | |
| Cost of Revenue | 2,648↑32.5% | 1,999↑7.2% | 1,864↑17.0% | 1,593↑18.4% | 1,345 | |
| Gross Profit | 1,419↑17.6% | 1,207↑11.9% | 1,079↑20.5% | 895↑17.7% | 760 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00↓100.0% | 116↓2.3% | 119↓2.0% | 121↑5.6% | 115 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 53↑18.7% | 44↑40.1% | 32↑2.3% | 31 | |
| SG&A Expenses | 0.00↓100.0% | 169↑3.4% | 163↑6.8% | 153↑4.9% | 146 | |
| Other Expenses | 860↑82.7% | 471↑15.1% | 409↑30.9% | 313↑18.2% | 264 | |
| Operating Expenses | 860↑34.5% | 640↑11.8% | 572↑23.0% | 465↑13.5% | 410 | |
| Total Costs & Expenses | 3,508↑33.0% | 2,639↑8.3% | 2,437↑18.4% | 2,058↑17.3% | 1,755 | |
| Operating Results | ||||||
| Operating Income | 559↓1.5% | 567↑12.0% | 506↑19.9% | 422↑15.8% | 365 | |
| Depreciation & Amortization | 225↑59.9% | 140↑11.8% | 126↑9.9% | 114↓0.7% | 115 | |
| EBITDA | 783↑10.7% | 708↑12.0% | 632↑23.0% | 514↑14.5% | 449 | |
| EBIT | 559↓1.5% | 567↑12.4% | 504↑26.2% | 400↑19.8% | 334 | |
| Interest & Other Income | ||||||
| Net Interest Income | -150↓41.0% | -107↓2.5% | -104↓47.7% | -70↓68.5% | -42 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 150↑41.0% | 107↑2.5% | 104↑47.7% | 70↑68.5% | 42 | |
| Non-Operating Income | 0.00↑100.0% | -0.04↓102.1% | 2↓91.9% | 23↓26.6% | 31 | |
| Other Income / Expenses | -9↑85.4% | -64↑39.9% | -106↓13.6% | -93↓28.0% | -73 | |
| Income Before Tax | 550↑9.2% | 503↑25.8% | 400↑21.6% | 329↑12.8% | 292 | |
| Income Tax Expense | 9↓50.7% | 18↑22.4% | 15↓55.8% | 34↑99.0% | 17 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 541↑11.4% | 485↑25.9% | 385↑21.1% | 318↑4.0% | 306 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 538↑14.2% | 471↑30.8% | 360↑31.2% | 274↑6.1% | 259 | |
| Bottom-Line Net Income | 538↑14.2% | 471↑30.8% | 360↑31.2% | 274↑6.1% | 259 | |
| EPS (Basic) | 5.32↑10.1% | 4.83↑30.5% | 3.70↑21.3% | 3.05↑6.3% | 2.87 | |
| EPS (Diluted) | 5.32↑10.1% | 4.83↑30.5% | 3.70↑21.3% | 3.05↑6.3% | 2.87 | |
| Weighted Average Shares | 101↑3.7% | 97↑0.1% | 97↑8.2% | 90↑0.0% | 90 | |
| Weighted Average Diluted Shares | 101↑3.7% | 97↑0.1% | 97↑8.2% | 90↑0.0% | 90 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.